AI assistant
Sending…
STRATA Skin Sciences, Inc. — Director's Dealing 2018
Apr 10, 2018
35146_dirs_2018-04-10_9abbc5ea-bbf1-4fed-a07b-590fc250ffe9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-04-10
Reporting Person: Rafaeli Dolev (Director, CEO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| SSKN Stock Options | $1.12 | 2028-03-30 | SSKN Stock (1557628) | Direct |
Footnotes
F1: The options vest over a period of three (3) years, with equal installments vesting each three (3) calendar months period, on the first day of the calendar month following the end of the three month period. The vesting period begins on the first calendar day following the closing of the investment disclosed in the Company's Current Report on Form 8-K filed April 2, 2018. In the event that closing does not occur, the options will expire.
More from STRATA Skin Sciences, Inc.
Regulatory Filings
2026
Feb 11
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 10
Director's Dealing
2025
Nov 18
Interim / Quarterly Report
2025
Nov 14
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 7
Proxy Solicitation & Information Statement
2025
Oct 30
Regulatory Filings
2025
Oct 20
Regulatory Filings
2025
Oct 16